Buy Gland Pharma, target price Rs 2240: Motilal Oswal

Gland Pharma Ltd. key Products/Revenue Segments include Pharmaceuticals, Sale of services, Other Operating Revenue and Export Incentives for the year ending 31-Mar-2023.

By ETMarkets.com | Updated: Mar 21, 2024, 09.20 AM IST

Promoters held 57.86 per cent stake in the company as of 31-Dec-2023, while FIIs owned 4.05 per cent, DIIs 24.17 per cent.

Motilal Oswal has buy call on Gland Pharma Ltd. with a target price of Rs 2240. The current market price of Gland Pharma Ltd. is Rs 1717.55.

Gland Pharma Ltd., incorporated in the year 1978, is a Small Cap company (having a market cap of Rs 28011.68 Crore) operating in Pharmaceuticals sector.

Gland Pharma Ltd. key Products/Revenue Segments include Pharmaceuticals, Sale of services, Other Operating Revenue and Export Incentives for the year ending 31-Mar-2023.

Financials
For the quarter ended 31-12-2023, the company reported a Consolidated Total Income of Rs 1582.55 Crore, up 10.93 % from last quarter Total Income of Rs 1426.58 Crore and up 58.29 % from last year same quarter Total Income of Rs 999.80 Crore. Company reported net profit after tax of Rs 191.86 Crore in latest quarter.

Promoter/FII Holdings
Promoters held 57.86 per cent stake in the company as of 31-Dec-2023, while FIIs owned 4.05 per cent, DIIs 24.17 per cent.

Not making enough money in stocks? Click here for real-life stories of successful investors.

Too busy to trade in stocks? Invest in Mutual Funds with ET Money!